HIMS

Hims Hers Health Inc

HIMS.US hims.com + Research + Basket
CIK 0001773751
Employees 2,442
Phone 415 851 0195
Fiscal year end December
IPO Sep 13, 2019
Address 2269 Chestnut Street, San Francisco, CA, United States, 94123
27.68
-1.99 (-6.71%)
USD · NYSE
52-week range
13.74
48.34
Trading at 40% of the 52-week range
Market Cap
6.92B
P/E Ratio
0.00
Forward P/E
76.34
Book Value
1.39
Div. Yield
N/A
% Institutions
71.12%
% Insiders
4.95%

1 Year

-37.2%

3 Year

+362.9%

10 Year

+182.4%
Description

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.

Actions

Add an action for HIMS.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Andrew Dudum Co-Founder, Chairman & CEO 1988
Mr. Mike Chi Chief Operating Officer 1980
Mr. Mohamed ElShenawy Chief Technology Officer 1975
Ms. Soleil Teubner Boughton J.D. Chief Legal Officer & Corporate Secretary 1978
Dr. Patrick Carroll M.D. Global Chief Medical Officer 1958
Dr. Daniel Lieberman M.D. Senior Vice President of Mental Health NA
Dr. Craig Primack M.D. Senior Vice President of Weight Loss NA
Mr. Dan Kenger Chief Design Officer NA
Dr. Jessica Shepherd FACOG, M.B.A., M.D. Chief Medical Officer of Hers NA
Ms. Janet Stevens Global Head of Quality & Safety NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Apr 20, 2026 Soleil Boughton N/A Sale 9.46K $30.00 $283.89K SEC
Apr 20, 2026 Oluyemi Okupe N/A Sale 19.65K $29.96 $588.56K SEC
Apr 17, 2026 Oluyemi Okupe N/A Sale 18.01K $27.83 $501.08K SEC
Apr 16, 2026 Oluyemi Okupe N/A Sale 36.92K $25.90 $956.28K SEC
Apr 06, 2026 Oluyemi Okupe N/A Sale 3.98K $19.98 $79.42K SEC
Mar 20, 2026 Oluyemi Okupe N/A Sale 9.22K $23.77 $219.09K SEC
Mar 17, 2026 Irene Becklund N/A Sale 5.53K $24.69 $136.51K SEC
Mar 17, 2026 Michael Chi N/A Sale 97.29K $24.69 $2.40M SEC
Mar 17, 2026 Soleil Boughton N/A Sale 4.81K $24.69 $118.81K SEC
Feb 03, 2026 Tony Wied N/A Purchase N/A $25.53 N/A —
Jan 20, 2026 Oluyemi Okupe N/A Sale 9.07K $30.34 $275.09K SEC
Jan 05, 2026 Oluyemi Okupe N/A Sale 9.07K $33.79 $306.48K SEC
Dec 22, 2025 Oluyemi Okupe N/A Sale 23.09K $35.72 $824.77K SEC
Dec 17, 2025 Deborah M Autor N/A Sale 7.05K $36.71 $258.95K SEC
Dec 17, 2025 Irene Becklund N/A Sale 8.41K $36.71 $308.77K SEC
Dec 17, 2025 Michael Chi N/A Sale 13.75K $36.71 $504.76K SEC
Dec 17, 2025 Patrick Harrison Carroll N/A Sale 10.02K $36.71 $367.87K SEC
Dec 09, 2025 Garcia Andrea G Perez N/A Sale 2.50K $39.17 $97.93K SEC
Nov 17, 2025 Oluyemi Okupe N/A Sale 23.19K $36.81 $853.51K SEC
Nov 17, 2025 Oluyemi Okupe N/A Sale 23.19K $36.81 $853.51K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 28.70M Jun 30, 2026 12.30% $0.01 8.98%
Vanguard Portfolio Management, LLC 10.56M Jun 30, 2026 4.53% $0.02 3.69%
Vanguard Capital Management, LLC 9.54M Jun 30, 2026 4.09% $0.01 2.16%
State Street Corp 8.15M Jun 30, 2026 3.49% $0.01 9.19%
Morgan Stanley - Brokerage Accounts 7.15M Jun 30, 2026 3.07% $0.01 -19.54%
Divisadero Street Capital Management, LP 6.01M Jun 30, 2026 2.58% $4.72 1,179.07%
Geode Capital Management, LLC 5.68M Jun 30, 2026 2.44% $0.01 9.29%
The Goldman Sachs Group Inc 5.17M Jun 30, 2026 2.22% $0.02 110.77%
JPMorgan Chase & Co 4.77M Jun 30, 2026 2.04% $0.01 -9.05%
FMR Inc 4.32M Jun 30, 2026 1.85% $0.01 4,535.24%
Marshall Wace Asset Management Ltd 4.22M Jun 30, 2026 1.81% $0.12 482.38%
UBS Group AG 2.66M Jun 30, 2026 1.14% $0.01 -35.91%
Northern Trust Corp 2.59M Jun 30, 2026 1.11% $0.01 6.50%
Charles Schwab Investment Management Inc 2.45M Jun 30, 2026 1.05% $0.01 4.03%
State Treasurer State Of Michigan 2.35M Jun 30, 2026 1.01% $0.36 0.33%
Bank of America Corp 2.31M Jun 30, 2026 0.99% $0.01 -46.94%
Principal Financial Group Inc 1.67M Jun 30, 2026 0.71% $0.03 30.01%
Vanguard Fiduciary Trust Co 1.52M Jun 30, 2026 0.65% $0.01 5.03%
Bank of New York Mellon Corp 1.33M Jun 30, 2026 0.57% $0.01 -0.54%
Schroder Investment Management Group 1.13M Jun 30, 2026 0.48% $0.03 54.18%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Mid-Cap ETF 7.53M 3.23% ▼ 0.04% Sep 30, 2026
2 Vanguard MStar Total Stk Mkt Idx Invest 6.75M 2.89% ▲ 0.27% Sep 30, 2026
3 iShares Russell 2000 ETF 5.58M 2.39% ▼ 1.14% Sep 30, 2026
4 Vanguard Small Cap Index 4.81M 2.06% ▼ 1.42% Sep 30, 2026
5 Vanguard MStar Small Cap Growth Indx Inv 2.68M 1.15% ▼ 4.29% Sep 30, 2026
6 Fidelity Small Cap Index 2.36M 1.01% ▲ 0.83% Jul 31, 2026
7 iShares Russell 2000 Growth ETF 2.02M 0.87% ▼ 0.13% Sep 30, 2026
8 JPMorgan Large Cap Growth I 1.98M 0.85% ▲ 0.00% Aug 31, 2026
9 State Street® SPDR® S&P MIDCAP 400® ETF 1.56M 0.67% ▲ 0.87% Sep 30, 2026
10 Vanguard Russell 2000 ETF 1.26M 0.54% ▲ 1.14% Sep 30, 2026

Financial Highlights

▼
Market Cap: $6.92B
EBITDA: $-10.18M
PEG Ratio: $2.67
Book Value: $1.39
Earnings/Share: $-0.64
Profit Margin: -5.51%
Operating Margin: -12.75%
ROA (TTM): -2.21%
ROE (TTM): -32.03%
Revenue (TTM): $2.58B
Revenue/Share (TTM): $11.29
Earnings Growth (YOY): -17.40%
Revenue Growth (YOY): 38.20%

Valuation Metrics

Enterprise Value: $7.55B
Trailing P/E: 0.00
Forward P/E: 76.34

Shares Statistics

Shares Outstanding: 224.94M
Shares Float: 213.75M
% Insiders: 4.95%
% Institutions: 71.12%
Shares Short: 53.47M
Shares Short (Prior Month): 52.92M
Short Ratio: 5.12
Short % Float: 27.55%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$2.35B
Cost of Goods Sold
adjust
$-614.26M
Gross Profit
subtotal
$1.73B
SG&A
adjust
$-272.72M
R&D
adjust
$-149.30M
Other Operating Expense
adjust
$-1.21B
Operating Income
subtotal
$105.61M
Other / Non-Operating Items
adjust
$22.75M
Net Income
subtotal
$128.37M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about HIMS.US!